Advertisement
Advertisement
NexgenRx Inc. (NEGXF)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
As of 03:30PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.2021 |
| Open | 0.2022 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.2021 - 0.2021 |
| 52 Week Range | 0.0110 - 0.3217 |
| Volume | |
| Avg. Volume | 258 |
| Market Cap | 17.428M |
| Beta (5Y Monthly) | 0.18 |
| PE Ratio (TTM) | 6.74 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.01 (7.21%) |
| Ex-Dividend Date | Sep 30, 2022 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for NEGXF
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- NEXGENRX INCAnalyst Report: Chubb LimitedACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.RatingFair ValueEconomic Moat3 months agoMorningstar
- Simply Wall St.
If EPS Growth Is Important To You, NexgenRx (CVE:NXG) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
- Simply Wall St.
Declining Stock and Solid Fundamentals: Is The Market Wrong About NexgenRx Inc. (CVE:NXG)?
NexgenRx (CVE:NXG) has had a rough three months with its share price down 19%. However, stock prices are usually driven...
- Simply Wall St.
Will Weakness in NexgenRx Inc.'s (CVE:NXG) Stock Prove Temporary Given Strong Fundamentals?
With its stock down 19% over the past three months, it is easy to disregard NexgenRx (CVE:NXG). However, a closer look...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
